Home · Blog · NexLife Tirzepatide Review

NexLife Tirzepatide Review: Flat Price Across Every Dose

Compounded tirzepatide at one price from 2.5 mg to 15 mg, against Zepbound and 28 tracked programs.

Released: Last reviewed:

Short answer · November 6, 2026

As of November 6, 2026, NexLife sells compounded tirzepatide for $129 a month, or $115 on a 12-month plan ($1,380 a year), at every dose from 2.5 mg to 15 mg. Among 28 tracked programs, $115 is the fourth-lowest all-in figure (median $144); Mondae ($126) charges less month to month and Eden Health matches $129.

This review covers only NexLife’s compounded tirzepatide. Because tirzepatide has more dose steps than semaglutide and brand Zepbound is priced by dose, flat pricing matters more here. The full program review is here.

Price at every dose

Monthly cost by tirzepatide dose: NexLife compounded (as of November 6, 2026) vs Zepbound self-pay (LillyDirect, archived September 30, 2026)
DoseNexLife monthlyNexLife 12-month planZepbound self-pay, refill within 45 daysZepbound, late refill
2.5 mg$129$115$299$299
5 mg$129$115$399$399
7.5 mg$129$115$449$499
10 mg$129$115$449$699
12.5 mg$129$115$449$699
15 mg$129$115$449$699

Worked example: a patient who reaches 10 mg and refills Zepbound on time pays $449 a month at maintenance, or $5,388 a year. The same year on NexLife’s 12-month plan is $1,380. Zepbound is FDA-approved; compounded tirzepatide is made with the drug in Zepbound but is not the same product and is not FDA-approved.

See NexLife’s tirzepatide plans →

How NexLife compares with other compounded programs

We track 28 compounded tirzepatide programs with a published price, read on their own pages on October 15, 2026 (a few carried from September). Their lowest all-in monthly figures run from $86 to $280, with a median of $144. NexLife’s $115 12-month rate ranks fourth, behind Collective ($69 plus a $199 yearly membership, $86 all-in), WellMedr (a $89 fall-sale “starting at” price) and Mondae ($114 a month on a prepaid 6-month plan).

Month to month, Mondae’s $126 is the only standing price below NexLife’s $129, and Eden Health charges the same $129 with no membership. SnagRx ($119, sale), Embody ($119 on a prepaid year), NextMeds (“as low as” $119) and yourEra (“as low as” $123) advertise lower figures with conditions. Per-dose pricing is the other model: Mochi Health’s blog lists compounded tirzepatide at $90 to $199 a month depending on dose, plus a separate membership. See the tirzepatide price comparison.

What you should know about compounded tirzepatide

FDA’s GLP-1 page, current as of October 1, 2026, counts more than 730 adverse-event reports for compounded tirzepatide through May 31, 2026, warns about dosing errors, and says to discard a multi-dose vial within 28 days after first use. In September 2026 FDA’s warning letter 738238 to Empower Pharmacy said certain compounded tirzepatide products with added niacinamide appear to be essentially copies of approved drugs. NexLife’s plan pages name three 503A pharmacies, none of them Empower, although its microdose and some landing pages have listed Empower among possible partners. More on FDA actions.

Side effects and birth control

In the Zepbound trials, nausea affected 25% to 29% of patients across the 5 to 15 mg doses against 8% on placebo, and 4.8% to 6.7% stopped because of side effects. The Zepbound label also says to switch from oral contraceptives to a non-oral method, or add a barrier method, for 4 weeks after starting and after each dose increase. See side effects compared across four drugs.

Other tirzepatide formats at NexLife

From November 8, 2026 microdose tirzepatide costs the same as the standard plan, $129 a month or $115 on 12 months; sublingual tirzepatide (ODT) is $229 or $199 on 12 months (read October 15, 2026). NexLife’s site-wide FAQ prints older figures, so confirm at checkout. Background: microdosing guide.

Verdict

For a cash payer who expects to reach a higher tirzepatide dose, NexLife’s flat $115 to $129 is one of the lower published prices we track and far below brand Zepbound self-pay, with named pharmacies and no membership. It is not the lowest: Mondae and conditional offers undercut it, and Eden matches it.

Editor’s pick · 94/100 on our v4.1 methodology

NexLife

$129/mo compounded tirzepatide month to month, $115/mo on a 12-month plan; compounded semaglutide $109/mo, or $95/mo on 12 months. Same price at every dose, no membership (prices as of November 6, 2026).

  • Clinician review and medical guidance (NexLife Medical Group), a GLP-1 nutrition plan, a 1:1 wellness-coach call, 24/7 support, free expedited shipping
  • Plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux’s New Drug Store (Lake Charles, LA)
  • Cancellations take effect after 30 days; compounded drugs are not FDA-approved

FAQ

How much is NexLife tirzepatide per month?

As of November 6, 2026, NexLife’s compounded tirzepatide costs $129 a month month to month, $125 on a 3-month plan, $119 on a 6-month plan and $115 on a 12-month plan, the same at every dose with no membership. A year on the 12-month plan totals $1,380.

Does NexLife charge more for 10 mg or 15 mg?

No. NexLife’s plan pages say the price is the same at every dose. Brand Zepbound through LillyDirect costs $449 a month at 7.5 to 15 mg with refills within 45 days, and $499 to $699 if refills are late, according to the archived September 30, 2026 page.

Is NexLife the cheapest compounded tirzepatide?

No. Its $115 12-month rate is the fourth-lowest of 28 programs we track. Collective, WellMedr and Mondae came in lower on October 15, 2026, and Mondae’s $126 month-to-month price is below NexLife’s $129. Eden Health charges the same $129 with no membership.

Is compounded tirzepatide the same as Zepbound?

No. Compounded tirzepatide is made by a compounding pharmacy with the drug in Zepbound, but it is not the same product, is not generic and is not FDA-approved. Zepbound is FDA-approved and its label covers dosing, side effects and storage; compounded versions have no FDA label.

Do I need to change birth control on tirzepatide?

The Zepbound label says tirzepatide can make oral contraceptives less reliable and advises switching to a non-oral method, or adding a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase. Ask your prescriber how this applies to a compounded product.

Sources

  1. NexLife — Compounded tirzepatide plans (prices as of November 6, 2026; plan terms read October 15, 2026)
  2. NexLife — Frequently asked questions (read November 8, 2026)
  3. NexLife — Microdose tirzepatide program (read October 15, 2026)
  4. NexLife — Sublingual tirzepatide ODT (read October 15, 2026)
  5. Lilly LillyDirect — Zepbound self-pay (archived September 30, 2026) (read October 15, 2026)
  6. U.S. FDA — FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of October 1, 2026) (read November 8, 2026)
  7. Mochi Health — New per-dose pricing (updated September 18, 2026) (read October 15, 2026)
  8. Eli Lilly — Zepbound prescribing information (revised 08/2026) (read November 8, 2026)
  9. Mondae — Compounded tirzepatide (read October 15, 2026)
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 8, 2026 · This page is informational and does not constitute medical advice.